About Africa Pharmaceutical Industry

• Africa has emerged as world's fastest growing economic regions over past 2 decades

• Pharma industry of Africa projected 9.8% annual growth rate between 2010 & 2020

• Africa market will be worth USD 40 billion to USD 65 billion by 2020

• Africa GDP rising to USD 3.9 Trillion by 2020

• New Regulatory Agency & efforts to augment economic growth, will positively contribute to growing pharma sector & attract foreign investments

• In many African countries, generic drugs are gaining market share at the expense of over-the-counter and branded products


Advantage of South Africa

• South Africa pharma industry to grow @5.8% / annum to Yr 2020 with value will have risen from USD 20 bn (Yr 2013) to USD 40+ bn

• South Africa is one of the four established markets in Africa, accounted for more than half of all pharmaceutical sales in Africa in recent years

• South Africa was predominantly a generic manufacturing industry and was rated 46 in the list of global exporters of pharmaceutical products

• South Africa’s pharmaceutical market is one of the most attractive markets in Africa. Some of the main reasons for its rapid growth are:

     1. the availability of cost-effective and skilled labor
     2. high quality infrastructure,
     3. Introduction of the South African Health Products Regulatory Authority (SAHPRA)

• The value of the South African pharmaceutical market at USD 3.8 billion in 2011, and expects it to reach USD 7 billion in 2018 at a Compound Annual Growth Rate (CAGR) of 9.2%

• In South Africa along side of other African nations, generics grew at an average CAGR of 22.3 % between 2004 and 2011, considerably faster than the 13.4 % for pharmaceuticals as a whole, this trend looks set to continue

• The South African private pharmaceutical industry is expected to reach R47 bn by 2020, increasing by 38% between year 2016 – 2020